TRANSFORM-HF trial found no difference in effectiveness between 2 common loop diuretics miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Secondary analyses from 13,026 people with type 2 diabetes and CKD in the finerenone pivotal trials showed that the agent was linked with less infective pneumonia and blunted COVID-19 severity.
New analysis adds to growing body of evidence in support of the use of sotagliflozin, an investigational dual SGLT1 and SGLT2 inhibitor, in the treatment of heart failure